NCT00806624 - DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation | Biotech Hunter

Enrollment

234

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

November 30, 2009

Conditions

Atrial FibrillationStroke

Interventions

DRUG

DU-176b tablets

DU-176b tablets taken once daily for up to 3 months

DRUG

DU-176b tablets

DU-176b tablets taken once daily for up to 3 months

DRUG

Warfarin tablets

Warfarin tablets taken once daily for up to 3 months

Trial Locations (4)

Hong Kong

Singapore

Seoul

Taipei